Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Olanow

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
Clinical Neuropharmacology|April 1, 1987
Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's diseaseC W Olanow, M J Alberts
Progress in Brain Research|January 1, 1990
Autologous adrenal medulla to caudate nucleus transplantation in advanced Parkinson's disease: 18 month resultsD W Cahill, C W Olanow
Annals of Neurology|September 28, 1998
The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to realityC D Marsden, C W Olanow
Advances in Neurology|January 1, 1987
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's diseaseC W Olanow, M J Alberts
Arquivos De Neuro-Psiquiatria|September 1, 1982
[Neurologic manifestations of hyperparathyroidism. Study of 120 cases]G N Rizzo, C W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's diseaseR A Hauser, C W Olanow
Annual Review of Neuroscience|April 15, 1999
Etiology and pathogenesis of Parkinson's diseaseC W Olanow, W G Tatton
Neurology|July 1, 1984
AChR antibody titer and clinical response to thymectomy in MGC W Olanow, A D Roses
Current Opinion in Neurology|December 1, 1994
Metals and free radicals in neurodegenerationC W Olanow, G W Arendash
Annals of Neurology|September 28, 1998
Dopamine agonists and neuroprotection in Parkinson's diseaseC W Olanow, P Jenner, D Brooks
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Clinical Neuropharmacology|April 1, 1987
Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's diseaseC W Olanow, M J Alberts
Progress in Brain Research|January 1, 1990
Autologous adrenal medulla to caudate nucleus transplantation in advanced Parkinson's disease: 18 month resultsD W Cahill, C W Olanow
Annals of Neurology|September 28, 1998
The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to realityC D Marsden, C W Olanow
Advances in Neurology|January 1, 1987
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's diseaseC W Olanow, M J Alberts
Arquivos De Neuro-Psiquiatria|September 1, 1982
[Neurologic manifestations of hyperparathyroidism. Study of 120 cases]G N Rizzo, C W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's diseaseR A Hauser, C W Olanow
Annual Review of Neuroscience|April 15, 1999
Etiology and pathogenesis of Parkinson's diseaseC W Olanow, W G Tatton
Neurology|July 1, 1984
AChR antibody titer and clinical response to thymectomy in MGC W Olanow, A D Roses
Current Opinion in Neurology|December 1, 1994
Metals and free radicals in neurodegenerationC W Olanow, G W Arendash
Annals of Neurology|September 28, 1998
Dopamine agonists and neuroprotection in Parkinson's diseaseC W Olanow, P Jenner, D Brooks
Pageof 16